When Captain Chesley Sullenberger announced his early-stage Alzheimer's diagnosis, the media machine instantly pivoted to its default, exhausting gear: the pathos-laden obituary-in-advance. Headlines rushed to frame the man who glided Flight 1549 onto the Hudson River as someone now waiting for a storm he cannot land. Commentators traded in soft focus, treating a personal medical disclosure as a national tragedy rather than what it actually is: an exercise in clinical candor.
This reaction exposes a profound collective illiteracy regarding neurodegenerative conditions. Society views a cognitive diagnosis through a Hollywood lens, defaulting immediately to terminal helplessness while entirely erasing the reality of early-stage management. Sullenberger stated explicitly that names might not come easily and sleep can be difficult, yet the public commentary treated these routine neurological frictions as an abrupt evaporation of his entire identity.
We need to stop infantalizing public figures who share medical diagnoses. When a high-profile individual steps forward to demystify a condition, the public immediately strips them of agency, converting a medical fact into a metaphor for personal defeat. This is intellectually lazy. Neurological decline does not happen overnight like an engine flameout at three thousand feet. It is a gradient, and how individuals navigate that gradient matters far more than the diagnostic label itself.
For decades, aviation safety has operated on a radically different philosophy: threat and error management. Pilots are trained to anticipate system degradation, build redundancies, and maintain situational awareness precisely when parameters shift outside of normal bounds. Yet when medical systems face parallel realities, cultural discourse abandons logic for melodrama. People assume that because a brain changes, the person inside it ceases to be an active agent of their own life.
Sullenberger noted that his doctor, Dr. Gil Rabinovici, opened his eyes to the sheer scale of the pathology, affecting millions across demographic lines. By bringing this reality into the open, the response should not be collective mourning; it should be an interrogation of how we treat aging, cognitive variance, and public transparency. We isolate patients by wrapping them in pity before they have even finished processing the clinical data themselves.
Real advocacy does not look like a weeping profile piece. It looks like treating a person with Alzheimer's as a human being who still possesses the capacity for reason, contribution, and choice. The narrative that a cognitive diagnosis strips away a person's value is the real pathology here, and it is entirely self-inflicted by a culture terrified of biological decay.
Stop writing eulogies for people who are busy living.
